NexLife vs Ivim Health
How NexLife and Ivim Health compare on price, medication type, clinical oversight, and pharmacy transparency — with the trade-offs and who each may suit.
| NexLife | Ivim Health | |
|---|---|---|
| From / month | $186/mo* | Varies (verify) |
| Pricing model | Flat, dose-independent | Varies — see provider |
| Medication type | Compounded tirzepatide | Compounded + brand (verify) |
| FDA status | Not FDA-approved (compounded) | Varies by product |
| Clinical oversight | MD/DO-supervised | Clinician-led + coaching (verify) |
| Pharmacy / fulfillment | 503A & 503B (six disclosed) | Verify with provider |
| What's included | Meds, visits, labs, coaching | Medication via telehealth + coaching (verify) |
| Insurance | Cash-pay (HSA/FSA) | Cash-pay (verify) |
Pricing verified as of June 2026 — confirm current figures with each provider. Compounded medications are not FDA-approved.
Clinical model
NexLife uses MD/DO-supervised care with included lab review and titration support. Ivim Health operates a clinician-led + coaching (verify) model (compounded + brand (verify)). Eligibility and any prescription are determined by a licensed clinician in both cases, and outcomes are not guaranteed.
Pharmacy & fulfillment
NexLife discloses six partner pharmacies across the 503A and 503B pathways and offers certificates of analysis on request. Ivim Health fulfillment: Verify with provider. Compounded products from either pathway are not FDA-approved — see 503A vs 503B.
Strengths and trade-offs
NexLife
- Flat, dose-independent pricing ($186/mo, 12-mo plan)
- MD/DO-supervised under a named Medical Director
- Six disclosed partner pharmacies (503A + 503B)
- Labs and Care360 coaching included; unlimited messaging
- LegitScript-certified
- Compounded only — not FDA-approved
- Cash-pay with HSA/FSA only — no insurance billing
- No brand-name Wegovy®/Zepbound®
- Results vary by patient; eligibility not guaranteed
Ivim Health
- Telehealth GLP-1 with coaching
- Multiple product pathways (verify)
- Compounded portions not FDA-approved
- Pricing and inclusions: verify directly
- Oversight model: verify
Who each may be best for
NexLife may suit you if you want predictable flat pricing that doesn't rise with dose, MD/DO oversight, disclosed pharmacies, and bundled labs/coaching — and you're comfortable with compounded medication (not FDA-approved) paid cash-pay.
Ivim Health may suit you if you want an FDA-approved brand-name product and/or insurance pathways, and are comfortable with a higher or coverage-dependent cost.
Questions
Is NexLife or Ivim Health cheaper?
As of June 2026, NexLife starts at $186/month flat. Ivim Health is listed from Varies (verify). Compare total annual cost including visits and labs, not just the headline price. Compounded tirzepatide is not FDA-approved. See NexLife pricing
What's the main difference between NexLife and Ivim Health?
NexLife is flat-rate compounded tirzepatide with MD/DO oversight and disclosed 503A/503B pharmacies; Ivim Health is compounded + brand (verify) with a clinician-led + coaching (verify) model. Choose based on whether you want compounded vs brand, flat vs variable pricing, and your insurance situation.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.